Inogen, Inc.
Financials
Valuation Metrics
Inogen, Inc.'s Market Cap is $182M. At end of 2025 it was $183M. Ranked #2992 of 3,115 in US market (top 96%), #1371 of 1,472 on NASDAQ (top 93%), #190 of 203 in Health Care Equipment & Services (top 94%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $182M | US#2,992/3,115 Sec#190/203 |
| Revenue | $354M | US#2,365/3,115 Sec#150/203 |
| Net Income | $-25M | US—/3,115 Sec—/203 |
| Total Assets | $286M | US#2,912/3,115 Sec#178/203 |
| Net Assets | $175M | US#2,705/3,115 Sec#164/203 |
| Employees | 753 | US#2,098/3,115 Sec#149/203 |
| Value | ||
| P/B | 1.04x | US#515/3,115 Sec#20/203 |
| P/S | 0.51x | US#372/3,115 Sec#28/203 |
| FCF Yield | -5.32% | US—/3,115 Sec—/203 |
| Profitability | ||
| ROE | -14.07% | US#2,414/3,115 Sec#141/203 |
| ROA | -8.61% | US#2,626/3,115 Sec#154/203 |
| Op. Margin | -8.45% | US#2,502/3,115 Sec#153/203 |
| Revenue Growth | 3.15% | US#1,940/3,115 Sec#148/203 |
| Financial Health | ||
| Debt Ratio | 63.31% | US#699/3,115 Sec#77/203 |
| Total Debt | $16M | US#2,778/3,115 Sec#179/203 |
| FCF | $-10M | US#2,370/3,115 Sec#152/203 |
| Cash | $87M | US#2,304/3,115 Sec#145/203 |
| Current Ratio | 2.74x | US#866/3,115 Sec#88/203 |
| Performance | ||
| 1Y Return | -16.03% | US#2,211/3,115 Sec#148/203 |
| 1M Return | 30.17% | US#50/3,115 Sec#9/203 |
| From 52W High | -17.25% | US#1,167/3,115 Sec#106/203 |
| 1Y MDD | -38.00% | US#1,846/3,115 Sec#111/203 |
| Trading | ||
| Volume | 191,546 shares | US#2,470/3,115 Sec#174/203 |
| Trading Value | $1M | US#2,906/3,115 Sec#189/203 |
| Per Share | ||
| EPS | $-0.93 | US—/3,115 Sec—/203 |
| BPS | $6.59 | US#2,129/3,115 Sec#130/203 |
Company Info
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.